PubRank

Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors

Clinical Trial ID NCT02239900

PubWeight™ 14.93‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02239900

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. Oncoimmunology 2015 1.06
2 Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade. J Clin Invest 2015 0.98
3 Advances in immunotherapy for treatment of lung cancer. Cancer Biol Med 2015 0.95
4 Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications. Front Immunol 2015 0.92
5 In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment. Vaccine 2015 0.92
6 New strategies in immunotherapy for non-small cell lung cancer. Transl Lung Cancer Res 2015 0.89
7 Stereotactic radiation therapy combined with immunotherapy: augmenting the role of radiation in local and systemic treatment. Oncology (Williston Park) 2015 0.85
8 Strategies for combining immunotherapy with radiation for anticancer therapy. Immunotherapy 2015 0.84
9 Thyroid cancer. Lancet 2016 0.83
10 Clinical activity of ceritinib in ROS1-rearranged non-small cell lung cancer: Bench to bedside report. Proc Natl Acad Sci U S A 2016 0.82
11 Advances in targeted and immunobased therapies for colorectal cancer in the genomic era. Onco Targets Ther 2016 0.81
12 Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology 2016 0.81
13 Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer 2016 0.81
14 Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies. Front Oncol 2016 0.78
15 Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect. J Immunol Res 2015 0.78
16 The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer. Oncologist 2016 0.78
17 Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment. Onco Targets Ther 2016 0.75
18 Adjuvant immunotherapy in resected early non-small cell lung cancer-battle lost, hopefully not the war! J Thorac Dis 2016 0.75
Next 100